Valuation (64%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 120.01 | N/A |
| PEG Ratio (TTM) | -2.33 | N/A |
| P/S Ratio (TTM) | 0.99 | N/A |
| P/B Ratio (TTM) | 1.95 | N/A |
| P/FCF Ratio (TTM) | 8.88 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.66 | N/A |
| Price to 5YR AVG FCF Ratio | 8.85 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.00% | N/A |
| ROE (TTM) | 1.71% | N/A |
| Net Profit Margin (TTM) | 0.80% | N/A |
| ROIC 5YR AVG | 43.01% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -26.39% | 269.99% | 170.32% |
| Revenue | -0.71% | 9.56% | 10.26% |
| Net Income | -27.98% | 294.03% | 182.00% |
| Cash Flow | -2.00% | 72.65% | 43.16% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.56 | N/A |
| Quick Ratio (TTM) | 2.47 | N/A |
| D/E Ratio (TTM) | 0.01 | N/A |
| Interest Coverage (TTM) | 10.07 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 3.92 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 0.35% | N/A |